Inventor · Cambridge, MA, US

Jing Yang

29Patents
7h-index
35Co-inventors
65Inventor score

Filing activity: Apr 28, 2006 → Aug 7, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US7560112B2 Anti-il-6 antibodies, compositions, methods and uses Chemistry; Metallurgy 74 Active
US8226611B2 Anti-IL-6 antibodies, compositions, methods and uses Chemistry; Metallurgy 61 Active
USRE43672E1 Anti-IL-6 antibodies, compositions, methods and uses General 51 Active
US7833755B2 Anti-IL-6 antibody nucleic acid molecules and methods Chemistry; Metallurgy 49 Active
US8623362B2 Anti-IL-6 antibodies Chemistry; Metallurgy 48 Active
US8067003B2 Methods of treating conditions using anti-IL-6 antibodies Chemistry; Metallurgy 48 Active
US8568998B2 Methods of diagnosing, preventing and treating cancer metastasis Chemistry; Metallurgy 40 Active
US8013015B2 Small molecule inhibitors of ghrelin O-acyltransferase Physics 6 Active
US9107897B2 Methods for isolating mammalian retinal progenitor cells Chemistry; Metallurgy 4 Active
US9963675B2 Compositions and methods for treating retinal diseases Chemistry; Metallurgy 4 Active
US7547767B2 Growth arrest specific gene 6 peptides, antibodies, compositions, methods and uses Chemistry; Metallurgy 2 Active
US11739294B2 Compositions and methods for treating retinal diseases Chemistry; Metallurgy 1 Active
US12410399B2 Compositions and methods for treating retinal diseases Chemistry; Metallurgy 0 Active
US8329745B2 Small molecule inhibitors of ghrelin O-acyltransferase Physics 0 Active
US11753623B2 Compositions for treating retinal diseases and methods for making and using them Chemistry; Metallurgy 0 Active
US11202827B2 Dosage and administration of non-fucosylated anti-CD40 antibodies Chemistry; Metallurgy 0 Active
US9631016B2 Pen-injector device containing anti-IL-6 antibodies Chemistry; Metallurgy 0 Active
US12065488B2 Anti-IL-6 antibody Chemistry; Metallurgy 0 Active
US12410398B2 Methods of human retinal progenitor cell isolation and culture Chemistry; Metallurgy 0 Active
US11898147B2 CpG-oligodeoxynucleotide compounds in combination with immune modulators for cancer immunotherapy Chemistry; Metallurgy 0 Active
US10781422B1 Compositions and methods for treating retinal diseases Chemistry; Metallurgy 0 Active
US11213584B2 Dosage and administration of non-fucosylated anti-CD40 antibodies Chemistry; Metallurgy 0 Active
US10822585B2 Compositions and methods for treating retinal diseases Chemistry; Metallurgy 0 Active
US10041041B2 Compositions and methods for treating retinal diseases Chemistry; Metallurgy 0 Active
US11180549B2 Methods of suppressing rheumatoid arthritis using an anti-IL-6 antibody Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.